Boehringer Ingelheim, a pharmaceuticals maker has agreed to pay (Dollar) 650 million to settle the 4,000 lawsuits related to its blood-thinning drug Pradaxa. "Boehringer Ingelheim announced today that the company has reached a comprehensive settlement of state and federal cases in the US litigation regarding Pradaxa," it said in a statement. Boehringer Ingelheim insisted that it continued to stand behind the drug, which is used to prevent blood clots and stroke ...
via Medindia Health News
More READ 
Lake forest health and fitness http://ift.tt/1oCcegi
No comments:
Post a Comment